DeepSeek's $16bn round gives state institutions exceptional access while private investors surrender control
The Information has added important ownership detail to DeepSeek's nearly $16bn second financing. The reported 106bn-yuan round drew almost 30 investors and valued the laboratory at about $84.6bn. Participants included major technology and industrial companies, but also China Mobile, China Telecom, CICC, Citic Securities, China Life and the National AI Development Fund.
The distinction is in the legal structure. In DeepSeek's first outside round, most investors placed their money in a partnership controlled by founder Liang Wenfeng rather than receiving shares directly in the model company. They forfeited voting rights and accepted a five-year lock-up unless DeepSeek listed earlier. The national AI fund was the exception: it invested directly and received voting rights. The new reporting indicates that state-linked institutions again occupy a structurally privileged position.
That arrangement helps Liang raise extraordinary sums without giving a conventional venture syndicate meaningful control. It also makes the usual labels—private startup, state-backed champion, founder-controlled company—simultaneously true but incomplete. Corporate investors obtain financial exposure to the most prominent Chinese AI lab; public institutions gain access and influence closer to the operating company; Liang preserves authority over product and strategy.
Reuters previously reported a roughly $15bn round involving Tencent, CATL, GigaDevice, Meituan and Geely. The Information's account puts the final amount higher and explains who sits where in the capital structure. Neither report constitutes an audited cap table, and DeepSeek has not publicly confirmed all terms.
This is a substantive update to the earlier financing story because the rights matter as much as the cheque size. DeepSeek now has the capital to buy scarce compute and subsidise low-cost models, while its governance aligns the lab more closely with China's telecom, finance and industrial-policy institutions. The financing therefore does more than fund a competitor to American labs: it assembles a domestic coalition around one.